“CKD and Hanmi had smile in outpatient prescription market”

Published: 2016-10-21 13:55:38

Updated: 2016-10-21 13:55:38

In this 3^rd quarter’s outpatient prescription market, it was observed there was fierce competition among pharmaceutical companies.

In the top group, Chong Kun Dang(CKD) and Hanmi Pharm has an intense fight over the top position; moreover, Daewon Pharm, Astellas and Hanlim Pharm stimulated competition for higher prescriptions in the middle group.

Based on the data of a market research instit...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.